pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

immunocore PRESS RELEASE ARCHIVE

Feb 10, 2021

Citi Appointed as Depositary Bank for Immunocore Holdings plc’s ADR Programme

Dec 9, 2019

Immunocore announces dosing of first patient with third ImmTAC bispecific

Oct 31, 2019

Immunocore to Spotlight ImmTAC Platform Research at 2019 SITC Annual Conference

Oct 31, 2019

Immunocore to Spotlight ImmTAC Platform Research at 2019 SITC Annual Conference

Jul 18, 2019

Immunocore and Pulse Infoframe, Inc. Partner with Leading Academic Institutions to Launch First Global Patient Registry for Uveal Melanoma

May 16, 2019

Immunocore to Present New Tebentafusp (IMCgp100) Data in Advanced Melanoma at Upcoming 2019 ASCO Annual Meeting

Apr 3, 2019

Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma

Jan 15, 2019

Immunocore Names David Berman as Head of RandD

Jan 15, 2019

Immunocore Names David Berman as Head of RandD

Jan 4, 2019

Immunocore Appoints Bahija Jallal as Chief Executive Officer

May 22, 2018

Immunocore to Present New Data from IMCgp100-102 Trial in Metastatic Uveal Melanoma at 2018 ASCO Annual Meeting

Nov 9, 2016

Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

Jun 8, 2016

Immunocore’s ImmTAV Shown to Redirect the Immune System to Kill HIV-Infected Cells from Patients Treated with Antiretroviral Therapy

Jun 6, 2016

Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting

Jun 6, 2016

Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting

Jan 25, 2016

Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma

Jan 20, 2016

Immunocore Starts Clinical Trial with IMCgp100 in Combination with MedImmune Immunotherapies Durvalumab and Tremelimumab

Jul 16, 2015

Malin Announces Investment In UK-based Immunology Company: Immunocore

Jun 29, 2015

Immunocore and Lilly Announce Immunotherapy-Based Clinical Trial Collaboration in Melanoma

Jun 12, 2015

Immunocore Wins Emerging Star of the Year Award at the European Mediscience Awards 2015

Apr 20, 2015

Immunocore Announces Positive Clinical Trial Data for Novel First-in-Class Immunotherapy at AACR Annual Meeting 2015

Apr 8, 2015

Immunocore to Present IMCgp100 Clinical Trial Data at AACR Annual Meeting 2015

Mar 30, 2015

Immunocore Appoints Professor Sir John Bell to its Board of Directors

Mar 2, 2015

Immunocore to present at Cowen and Company 35th Annual Health Care Conference

Google Analytics Alternative